Home News Vaccine Distribution, Surge in Coronavirus Cases on Agenda as PM Modi Chairs Meet With States Tomorrow

Vaccine Distribution, Surge in Coronavirus Cases on Agenda as PM Modi Chairs Meet With States Tomorrow

News18 Logo

Prime Minister Narendra Modi is likely to hold virtual meetings with chief ministers of states and union territories on Tuesday to review their respective Covid-19 responses.

With vaccine candidates in second or third phase of clinical trials, vaccine distribution, emergency authorisation are also likely to be discussed with the states.

The PM will hold two separate meetings back-to-back meetings, of which one will be with the CMs or representative of the states reporting highest number of coronavirus cases.

After a recent Niti Aayog meeting, it was learned that the government is exploring the modalities of emergency authorisation and usage of anti-coronavirus vaccines pending completion of phase-three clinical trial and regular licensure.

The issue of advance purchase commitment for vaccines, including pricing, was also discussed at the meeting attended by NITI Aayog Member (Health) Vinod Paul, Principal Scientific Advisor to the government K VijayRaghavan and Union Health Secretary Rajesh Bhushan.

“It was decided that the PMO-constituted Vaccine Task Force (VTF) will lay down the principles for emergency use authorisation while the National Expert Group On Vaccine Administration for COVID-19

(NEGVAC) should take the lead in setting the principles for advance market commitment, including vaccine pricing,” a source said.

These developments assume significance against the backdrop of Pfizer seeking emergency use authorisation of its COVID-19

vaccine from the US regulators. Another US-based biotechnology giant, Moderna, said it also intends to apply for an emergency use authorisation (EUA) with the US Food and Drug Administration (USFDA) in the coming weeks. Meanwhile, five vaccines are under different phases of clinical trials in India.

The Serum Institute of India is conducting the phase-three trial of the Oxford-AstraZeneca COVID-19 vaccine, while Bharat Biotech and ICMR has already started the phase-three trail of the indigenously developed COVAXIN jab. An indigenously developed vaccine by Zydus Cadila has completed phase-two clinical trial in the country. Dr Reddy’s Laboratories will soon start combined phase two and three trials of the Russian COVID-19

vaccine Sputnik V in India.

According to the source, an urgent meeting of the vaccine task force (VTF) with experts will be convened to review the scientific status of vaccines globally and whether, if so how and when should the decision on emergency authorisation of vaccines be taken. The terms of references for two major bodies dealing with vaccine introduction — the National Technical Advisory Group on Immunisation (NTAGI) and the Central Drug Standards and Control Organisation (CDSCO) — will be set and their roles clearly defined for authorisation and emergency authorisation.

This article is auto-generated by Algorithm Source: www.news18.com

Related Posts